Innovative Eyewear Inc (LUCYW): Capital Expenditures

Annual figures by period end, from SEC filings.

$72.5K
Year ended 2025-12-31
-15.8%
3-year compound annual growth
$121.6K2021-12-31: $20.8K2022-12-31: $121.6K2023-12-31: $78.5K2024-12-31: $62.2K2025-12-31: $72.5K$72.5K
2021-12-31 Capital Expenditures (USD) 2025-12-31
Period endedCapital ExpendituresChange YoYSource filing
2025-12-31$72.5K+16.6%2026-03-25, From 2025-01-01
2024-12-31$62.2K-20.7%2026-03-25, From 2024-01-01
2023-12-31$78.5K-35.5%2025-03-24, From 2023-01-01
2022-12-31$121.6K+484.9%2024-03-25, From 2022-01-01
2021-12-31$20.8Kn/a2023-03-24, From 2021-01-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Ophthalmic Goods), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
Innovative Eyewear Inc (LUCYW)2025-12-31$72.5K+16.6%
RxSight, Inc. (RXST)2025-12-31$3.83M-29.6%
Staar Surgical Co (STAA)2026-01-02$5.82M-75.1%
Warby Parker Inc. (WRBY)2025-12-31$67.05M+4.7%
National Vision Holdings, Inc. (EYE)2026-01-03$72.84M-23.7%
Cooper Companies, Inc. (COO)2025-10-31$362.40M-14.0%
Bausch & Lomb Corp (BLCO)2025-12-31$349.00M+19.9%

Compare LUCYW, RXST, STAA, WRBY side by side · Screen every company in Ophthalmic Goods ↗